In Vitro vs In Vivo: Definitions, Lab Examples and Limits

In vitro vs in vivo is the difference between studying a biological process outside a living organism, in a tube, plate or dish, and studying it inside a whole living organism. The Latin says it directly: in vitro means “in glass” and in vivo means “within the living”. Ex vivo sits between the two: tissue taken from an organism and kept working outside it, usually for hours to days.

Most laboratory work moves along a ladder of four model levels: a cell-free assay, a cell culture, a tissue explant and a whole organism. Each step up adds biological context and loses control over the variables. This article walks through each level with examples, sets out what each can and cannot tell a researcher, and explains why reagent quality weighs most heavily at the in vitro end.

In vitro, ex vivo and in vivo at a glance

Source: Vortex Research Editorial Team, summarising the model-system reviews cited below [5, 6, 9, 10].

Research materials: Vortex supplies peptides as sealed lyophilised reagents for in vitro laboratory research. Browse the catalogue at /shop/. Third-party lab reports are published at /coa/.

What in vitro means

In vitro covers any experiment run outside a living organism. The “glass” in the name is historical; today it is usually polystyrene plates, plastic tubes and microfluidic chips. Two very different kinds of experiment share the label:

• Cell-free in vitro work uses purified molecules: an enzyme and its substrate, a receptor and a ligand, a peptide in a buffer. There are no living cells at all.
• Cell-based in vitro work uses living cells grown in a culture medium. The cells are alive, but they are no longer part of an organism.

Cell-free assays: the most controlled in vitro systems

A cell-free assay holds only what the researcher puts in. Concentrations, pH, temperature and ionic strength are all set, so a measured change can be attributed to a known component.

Enzyme kinetics is the classic example. In 1913 Leonor Michaelis and Maud Menten showed that the rate of an enzyme reaction follows the concentration of the enzyme-substrate complex. A 2011 translation and re-analysis found that they fitted full time-course data, not just initial rates, and accounted for product inhibition [1]. The same logic underlies plate-reader binding and enzyme assays today.

Cell-free assays have their own failure mode: a signal that comes from the chemistry of the assay rather than the biology. Screening chemists have catalogued substructures that appear as “frequent hitters” across many unrelated biochemical screens, called pan-assay interference compounds (PAINS), and cautioned that they are reported as starting points when they may not be [2]. A cell-free result should be confirmed with an orthogonal assay.

Cell culture: in vitro work with living cells

Cell culture adds a membrane, uptake and export, signalling networks and gene expression. Researchers use two broad kinds of cells:

• Primary cells, isolated directly from tissue. They stay closer to their tissue of origin but grow for a limited number of divisions and vary from donor to donor.
• Cell lines, which grow indefinitely. They are convenient and reproducible, but they have adapted to life on plastic, often over decades.

The weak point of cell culture is identity. Cell lines get swapped, mislabelled and overgrown by faster-growing neighbours. A 2001 study analysed 253 human cell lines from banks and institutes worldwide by short tandem repeat (STR) profiling. The authors cited national testing-service estimates that up to 36% of cell lines are of a different origin or species from the one claimed, and proposed the STR profile as an international reference standard for cell-line identity [3].

Two other variables sit in almost every culture flask:

• Mycoplasma. These small bacteria lack a cell wall, can pass through standard sterilising filters and are not visible under a routine light microscope. Detection relies on PCR or fluorescent in situ hybridisation, with control reactions to catch false negatives from inhibited reactions and false positives from contamination [4].
• Serum. Many media are supplemented with fetal bovine serum, an undefined mix whose composition varies by batch. A 2018 workshop report listed disadvantages in quality and reproducibility of in vitro data, as well as cases of fraudulent marketing, and described chemically defined serum-free media as the goal for most culture systems [5].

3D cultures and organs-on-chips

A flat monolayer on plastic is a long way from tissue, where cells are surrounded by other cells and extracellular matrix. A 2007 review argued that essential cellular functions present in tissue are missed in petri-dish culture, which limits how well such cultures predict the responses of real organisms [6]. A 2017 review listed the challenges that remain in 3D culture: the tissue-tissue interface, the mechanical microenvironment and the distribution of oxygen, nutrients and wastes [7].

Organs-on-chips push further. These are microfluidic devices with continuously perfused chambers in which living cells are arranged to reproduce tissue- and organ-level structure, including tissue-tissue interfaces and flow, and they allow real-time imaging of living cells [8]. They are still in vitro: there is no circulation beyond the chip and no other organs.

What ex vivo means

Ex vivo (“out of the living”) describes tissue or fluid taken from an organism and studied outside it while it is still functioning. It keeps its native mix of cell types and much of its architecture, but it starts to change from the moment it is removed.

Precision-cut tissue slices are a common ex vivo format: thin, uniform slices cut from fresh tissue and kept in culture for short periods. A 2016 review described precision-cut intestinal slices as a simple, fast ex vivo model for studying the transport and metabolism of xenobiotics, and as a link in in vitro-ex vivo-in vivo extrapolation, while noting that culture media and preservation methods still needed work [9].

Fresh blood and its fractions show how much the choice of matrix matters. A 2017 study compared peptides from three families in fresh mouse blood, serum and plasma. Peptides were generally degraded faster in serum than in plasma, all were more stable in fresh blood, and the order of degradation rates changed across the six incubation conditions [10]. The authors concluded that stabilising peptides against serum or plasma proteases may target cleavage sites that matter only in vitro.

What in vivo means

In vivo work uses a whole living organism, in laboratory science most often a rodent, zebrafish, fruit fly or nematode. It is the only level at which absorption, distribution, metabolism and clearance all operate together, with circulation, organs and their interactions intact.

The price of that realism is control. Genetics, housing, diet, microbiota, sex and the time of day can all affect a result. The ARRIVE guidelines (Animal Research: Reporting of In Vivo Experiments), first published in 2010 and revised as ARRIVE 2.0 in 2020, set out an “Essential 10” checklist of items a paper must report so that others can judge its rigour and repeat the work [11]. Animal work is also framed by the “3Rs” (Replacement, Reduction and Refinement), set out by William Russell and Rex Burch in 1959 [5].

In vitro vs in vivo: strengths and limits compared

Source: Vortex Research Editorial Team, drawing on references 3, 6, 7, 9 and 11.

The levels answer different questions, so a result at one level is a prompt for the next experiment, not a stand-in for it. A binding constant measured cell-free says nothing about whether a molecule reaches its target inside a cell. The wider reproducibility gap is large: a 2015 analysis estimated that the cumulative prevalence of irreproducible preclinical research exceeds 50%, costing about US$28 billion a year in the United States alone [12].

Why reagent quality matters most in vitro

The smaller the system, the larger the share of the result that comes from whatever is in the reagent. Even a contaminant at a fraction of a percent can reach a concentration that cultured cells respond to. Three examples:

Counter-ions

Peptides purified by reversed-phase HPLC usually arrive as trifluoroacetate (TFA) salts, because trifluoroacetic acid is used in the mobile phase. A 1999 study found that TFA itself, at 10^-8 to 10^-7 M, lowered cell numbers and thymidine incorporation in rat osteoblast cultures within 24 hours. Proliferation was consistently lower with TFA salts of the same peptides than with hydrochloride salts, which could hide a real effect or create a false one. The authors advised converting peptides to a hydrochloride salt for cell studies at concentrations above 10^-9 M [13]. Our explainer on research peptides explains why counter-ions and bound water are part of what is in a vial.

Endotoxin

Bacterial lipopolysaccharide is a potent signal to many cell types even at trace levels, so a reagent carrying endotoxin can produce a cell response that has nothing to do with the molecule being studied. Our endotoxin testing explainer covers how it is measured and reported.

Purity and content

A peptide-related impurity at 2% of the peak area is a second compound in the experiment. Net peptide content sets the real concentration in the well. Both appear on a lot report, and our article on HPLC peptide purity shows how the purity figure is calculated.

Checking a reagent lot before in vitro work

Before a peptide goes into a plate, the lot report should answer five questions:

1. Is it the right molecule? Look for identity by mass spectrometry or by retention time against a reference standard, and note which one was used.
2. How pure is it? Read the HPLC purity and its specification.
3. How much peptide is actually there? Use net content, not the labelled mass, to calculate working concentrations.
4. Which contaminant tests were run? Endotoxin, sterility and elemental impurities appear only where they were tested. Our article on sterility and heavy-metals testing explains each.
5. Does the lot code match? Record it in the lab notebook, so a result can be traced back to the batch used.

Vortex publishes its third-party reports, with links to each lab’s own verification portal, at /coa/. The tests listed vary by report.

Why research-use-only reagents are framed for in vitro work

A research-use-only (RUO) label places a reagent in a category: material supplied for laboratory investigation, documented by lot, without instructions for any other purpose. It is not a quality grade. The documents that come with an RUO peptide (a lot report, a specification and a lot code) are built for the questions in vitro work raises: what the molecule is, how pure it is, how much is present and which batch it came from. Our article on what the RUO label means covers the documentation in more detail.

Frequently asked questions

What is the difference between in vitro and in vivo?

In vitro work studies a process outside a living organism, in a tube, plate, dish or chip, either with purified molecules or with cultured cells. In vivo work studies it inside a whole living organism. In vitro offers control and throughput; in vivo includes absorption, distribution, metabolism and clearance together.

What does ex vivo mean?

Ex vivo means tissue or fluid taken from an organism and studied outside it while still functioning, such as precision-cut tissue slices or fresh blood. It keeps the native cell mix and structure for a limited time. It sits between cell culture and whole-organism work.

Is cell culture in vitro or in vivo?

Cell culture is in vitro. The cells are alive, but they grow in a dish or flask outside any organism. 3D cultures and organs-on-chips are also in vitro, even though they reproduce more of the structure of tissue.

Why does reagent purity matter more in vitro?

In a small, defined system the reagent makes up a large share of everything present, so impurities, counter-ions and endotoxin can produce a measurable signal of their own. A 1999 study, for example, found that trifluoroacetate counter-ions alone lowered proliferation counts in cell cultures. Lot reports with identity, purity and net content let a researcher account for this.

References

1. Michaelis L, Menten ML, Johnson KA, Goody RS. The original Michaelis constant: translation of the 1913 Michaelis-Menten paper. Biochemistry. 2011;50(39):8264-8269. PMID 21888353. doi:10.1021/bi201284u
2. Baell JB, Holloway GA. New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. J Med Chem. 2010;53(7):2719-2740. PMID 20131845. doi:10.1021/jm901137j
3. Masters JR, Thomson JA, Daly-Burns B, et al. Short tandem repeat profiling provides an international reference standard for human cell lines. Proc Natl Acad Sci U S A. 2001;98(14):8012-8017. PMID 11416159. doi:10.1073/pnas.121616198
4. Uphoff CC, Drexler HG. Detection of Mycoplasma contamination in cell cultures. Curr Protoc Mol Biol. 2014;106:28.4.1-28.4.14. PMID 24733240. doi:10.1002/0471142727.mb2804s106
5. van der Valk J, Bieback K, Buta C, et al. Fetal Bovine Serum (FBS): Past – Present – Future. ALTEX. 2018;35(1):99-118. PMID 28800376. doi:10.14573/altex.1705101
6. Pampaloni F, Reynaud EG, Stelzer EH. The third dimension bridges the gap between cell culture and live tissue. Nat Rev Mol Cell Biol. 2007;8(10):839-845. PMID 17684528. doi:10.1038/nrm2236
7. Duval K, Grover H, Han LH, et al. Modeling physiological events in 2D vs. 3D cell culture. Physiology (Bethesda). 2017;32(4):266-277. PMID 28615311. doi:10.1152/physiol.00036.2016
8. Bhatia SN, Ingber DE. Microfluidic organs-on-chips. Nat Biotechnol. 2014;32(8):760-772. PMID 25093883. doi:10.1038/nbt.2989
9. Li M, de Graaf IA, Groothuis GM. Precision-cut intestinal slices: alternative model for drug transport, metabolism, and toxicology research. Expert Opin Drug Metab Toxicol. 2016;12(2):175-190. PMID 26750630. doi:10.1517/17425255.2016.1125882
10. Böttger R, Hoffmann R, Knappe D. Differential stability of therapeutic peptides with different proteolytic cleavage sites in blood, plasma and serum. PLoS One. 2017;12(6):e0178943. PMID 28575099. doi:10.1371/journal.pone.0178943
11. Percie du Sert N, Hurst V, Ahluwalia A, et al. The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. PLoS Biol. 2020;18(7):e3000410. PMID 32663219. doi:10.1371/journal.pbio.3000410
12. Freedman LP, Cockburn IM, Simcoe TS. The economics of reproducibility in preclinical research. PLoS Biol. 2015;13(6):e1002165. PMID 26057340. doi:10.1371/journal.pbio.1002165
13. Cornish J, Callon KE, Lin CQ, et al. Trifluoroacetate, a contaminant in purified proteins, inhibits proliferation of osteoblasts and chondrocytes. Am J Physiol. 1999;277(5):E779-E783. PMID 10567002. doi:10.1152/ajpendo.1999.277.5.E779

Methods note: every PMID was checked against its PubMed record, and each abstract was read against the sentence that cites it.

Vortex Research products are sold for in-vitro laboratory research by qualified researchers. Not for human or veterinary use. Not a drug, dietary supplement or cosmetic. Statements have not been evaluated by the FDA.